tiprankstipranks
Bridgebio Pharma (BBIO)
NASDAQ:BBIO
BBIO
BridgeBio Pharma
RESEARCH TOOLSreports
Want to see BBIO full AI Analyst Report?

BridgeBio Pharma (BBIO) Revenue

1,481 Followers
StatisticsMarket CapRevenue

BridgeBio Pharma Revenue

BridgeBio Pharma had a revenue of 194.51M in the quarter ending Mar 31, 2026, with 26.16%. This bring the company's revenue in the last twelve months to 579.96M, Decreased 15.51%. In the fiscal year ending Dec 31, 2025, BridgeBio Pharma had annual revenue of 502.08M with 126.26% growth.
Revenue (ttm)
579.96M
Revenue Growth
355.17%
P/S Ratio
25.48
Revenue/Employee
$692,521
Employees
725
Market Cap
$12.79B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2025
502.08M280.18M+126.26%
Dec 31, 2024
221.90M212.60M+2,285.27%
Dec 31, 2023
9.30M-68.34M-88.02%
Dec 31, 2022
77.65M7.93M+11.38%
Dec 31, 2021
69.72M61.47M+745.14%
Dec 31, 2020
8.25M-32.31M-79.66%
Dec 31, 2019
40.56M―+∞%
Dec 31, 2018
―――
Dec 31, 2017
―――